The Asia Pacific Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Asia Pacific Examiner.

Press releases published on March 9, 2026

Mar. 9, 2026

New Century Logistics (BVI) Limited Regains Compliance with Nasdaq Minimum Bid Price Requirement

Indeterminate GlobeNewswire

Mar. 9, 2026

Carbon Revolution Provides Update on Strategic Transaction and Funding Efforts

Indeterminate GlobeNewswire

Mar. 9, 2026

GOWIN Semiconductor Announces New FPGA Families for 2026

Indeterminate GlobeNewswire

Mar. 9, 2026

Poster Presentation Demonstrating Combination Benefit of Narmafotinib in Preclinical Kras-Mutated Cancer Models

Indeterminate GlobeNewswire

Mar. 9, 2026

Genius Group announces 2025 Financial Results with 80% Pro Forma Revenue Growth to $13.6 Million

Indeterminate GlobeNewswire

Mar. 9, 2026

Nasus Pharma to Present Topline Analysis from NS002 Intranasal Epinephrine Powder Phase 2 Single and Repeat Dose Clinical Study

Indeterminate GlobeNewswire

Mar. 9, 2026

Biodexa Announces Support for Life’s a Polyp Foundation First U.S. Patient Advocacy Group for FAP Patients

Indeterminate GlobeNewswire

Mar. 9, 2026

Tenaya Therapeutics Presents Preclinical Data at MDA 2026 Highlighting TN-301’s Potential to Correct Skeletal and Cardiac Muscle Decline in Duchenne Muscular Dystrophy

Indeterminate GlobeNewswire

Mar. 9, 2026

Veru Enrolls First Patient in Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss

Indeterminate GlobeNewswire

Mar. 9, 2026

Powell Max Limited Successfully Repositions for Its Next Phase of Growth

Indeterminate GlobeNewswire

Mar. 9, 2026

YY Group Announces Preliminary Fiscal Year 2025 Financial Highlights

Indeterminate GlobeNewswire

Mar. 9, 2026

Founder Group Limited 斩获马来西亚 CGPP 计划中价值 400 万美元、装机 25.4 兆瓦的公用事业规模太阳能项目合同

Indeterminate GlobeNewswire

Mar. 9, 2026

Founder Group Limited Secures US$4 million 25.4MW Utility-Scale Solar Contract under Malaysia’s CGPP Programme

Indeterminate GlobeNewswire

Mar. 9, 2026

NovelMed Therapeutics Announces Regulatory Clearance for Subcutaneous Ruxoprubart and Reports Positive Phase II Intravenous Monotherapy Results in PNH

Indeterminate GlobeNewswire

Mar. 9, 2026

Aurora Mobile's EngageLab Launches OpenClaw Skills, Empowering AI Agents to Connect with the Real World

Indeterminate GlobeNewswire

Mar. 9, 2026

Ulcerative Colitis Market 2026: Advance Care Standards Through Innovative Gastrointestinal Treatment Approaches

Indeterminate EIN Presswire

Mar. 9, 2026

Personalized Nutrition & Supplements Market 2026:Leverage Customized Nutrition Solutions Accelerating Precision Wellness

Indeterminate EIN Presswire

Mar. 9, 2026

Pharma ADMET Testing Market to Reach $18,062.89 Bn by 2026 as Advanced ADMET Technologies Transform Drug Development

Indeterminate EIN Presswire

Mar. 9, 2026

Nasus Pharma to Present and Participate in the Upcoming Life Sciences Investor Forum

Indeterminate GlobeNewswire

Mar. 9, 2026

Galecto Announces Name Change to Damora Therapeutics with Mission to Fundamentally Redefine Care for Patients with Blood Disorders

Indeterminate GlobeNewswire